FORM OF indemnification agreementIndemnification Agreement • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of __________, 2024, is entered into by and between SciSparc Ltd., an Israeli company whose address is 20 Raul Wallenberg St., Tower A, 2nd Floor, Tel Aviv 6971916, Israel (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto officer (the “Indemnitee”).
Loan AgreementLoan Agreement • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This Loan Agreement (the “Agreement”) is made on January 14, 2024 (the “Effective Date”) by and between, SciSparc Ltd., an Israeli limited company (the “Lender”) and AutoMax Motors Ltd., an Israeli limited company (the “Borrower”).
PREFUNDED ORDINARY SHARE PURCHASE WARRANT SCISPARC LTD.Prefunded Ordinary Share Purchase Warrant • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This PREFUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the Merger Consideration (as defined in the Merger Agreement (as defined below), [HOLDER] (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date and until this Warrant is exercised in full, but not thereafter, to subscribe for and to purchase from SCISPARC LTD., a corporation incorporated in Israel with principal executive offices located at 20 Raul Wallenberg Street, Tower A Tel Aviv 6971916 Israel (the “Company”), up to [_] Ordinary Shares (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection wi
addendum no. 1 to AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This addendum, dated August 14, 2024 (the “Effective Date”) constitutes addendum no. 1 (the “Addendum”) to that certain Agreement and Plan Of Merger dated April 10, 2024 (hereinafter together, the “Agreement”), by and between, SciSparc Ltd., an Israeli limited company (the “Parent”), SciSparc Merger Sub Ltd., an Israeli limited company and wholly-owned subsidiary of Parent (“Merger Sub”), and AutoMax Motors Ltd., an Israeli limited company (the “Company”).
AMENDMENT TO LOAN AGREEMENTLoan Agreement • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This Amendment (the “Amendment”) to that certain Loan Agreement (“Loan Agreement”) dated January 14, 2024 (the “Effective Date”), by and between SciSparc Ltd., an Israeli limited Company (the “Lender”), and AutoMax Motors Ltd., an Israeli limited company (the “Borrower”), is entered into effect as of June 9, 2024 (the “Amendment Effective Date”).
AMENDMENT No. 2 TO LOAN AGREEMENTLoan Agreement • September 26th, 2024 • SciSparc Ltd. • Pharmaceutical preparations
This Amendment (the “Amendment”) to that certain Loan Agreement dated January 14, 2024, as amended by Amendment dated June 9, 2024 (together, the “Loan Agreement”), by and between SciSparc Ltd., an Israeli limited Company (the “Lender”), and AutoMax Motors Ltd., an Israeli limited company (the “Borrower”), is entered into effect as of September 5, 2024 (the “Amendment Effective Date”).
